文献速递系统性红斑狼疮

获得性低免疫球蛋白水平与成人系统性红斑狼疮临床相关感染风险的队列研究

Acquired low immunoglobulin levels and risk of clinically relevant infection in adult patients with systemic lupus erythematosus: a cohort study.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该前瞻性队列研究比较了成人SLE患者中获得性低免疫球蛋白水平(IgA、IgM或IgG)持续2年与正常或高水平患者发生临床相关感染的风险。结果显示,仅低IgA水平与临床相关感染风险增加相关(HR 2.24,95%CI 1.61-3.12),而低IgG或低IgM无显著关联。大多数获得性低免疫球蛋白血症在4年内恢复。

要点

  • 低IgA水平与临床相关感染风险增加独立相关(HR 2.24)。
  • 低IgG或低IgM水平未显示与感染风险增加相关。
  • 60%的获得性低免疫球蛋白血症在4年内恢复。

核心结论

  • 成人SLE患者中大多数获得性低免疫球蛋白血症是短暂的。
  • 仅获得性低IgA水平与临床相关感染风险增加相关。

研究设计与样本

  • 前瞻性队列研究,比较获得性低免疫球蛋白水平(IgA、IgM或IgG)持续2年的成人SLE患者与水平正常或升高者。
  • 采用倾向评分调整、匹配和逆概率加权实现组间平衡。
  • 主要分析采用Cox回归模型调整潜在混杂因素,并进行了敏感性分析。

主要发现

  • 低丙种球蛋白血症患者病程更长、狼疮肾炎病史更多、蛋白尿更高、累积损伤更多。
  • 低IgA水平与临床相关感染风险增加相关(HR 2.24,95%CI 1.61-3.12)。
  • 低IgG水平(HR 1.15,95%CI 0.84-1.59)或低IgM水平(HR 0.95,95%CI 0.73-1.23)与感染风险无显著关联。
  • 低免疫球蛋白恢复率:第一年2.5%(11例),第二年8.2%(36例),第三年10.1%(44例),第四年18.4%(80例)。
  • 60%(263例)的获得性低丙种球蛋白血症在4年内恢复。

关键数值与推荐

  • 临床相关感染定义为需要静脉或口服抗生素治疗的感染。
  • 获得性低免疫球蛋白水平定义为任何类型免疫球蛋白(IgA、IgM或IgG)水平低持续2年。

临床怎么用

  • 对于成人SLE患者,应关注获得性低IgA水平,其与临床相关感染风险增加相关。
  • 获得性低免疫球蛋白血症多为短暂,需长期随访监测恢复情况。
  • 免疫球蛋白替代治疗是否提供额外保护作用尚需进一步研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Infection is a leading cause of death in the SLE population. Low immunoglobulin levels might be a potential risk for infection. We aimed to assess whether acquired low levels of any type of immunoglobulin increase the risk of clinically relevant infection in adult patients with SLE. METHODS: We compared adult SLE patients who had acquired any low immunoglobulin levels (IgA, IgM or IgG) for 2 years with patients with normal or high levels with respect to clinically relevant infection (defined as infections requiring intravenous or oral antibiotics) in a prospective cohort study. Group balance was achieved using propensity score adjustment, matching and inverse probability weighting. Primary analysis was time to event using Cox-regression modelling adjusting for potential confounders. Sensitivity analyses were conducted to examine several exposure and outcome definitions. RESULTS: Patients with hypogammaglobulinaemia had longer disease duration, more lupus nephritis history, higher proteinuria and more accumulated damage. Low IgA level was associated with increased risk of clinically relevant infection [hazard ratio (HR): 2.24, 95% CI: 1.61, 3.12] while low IgG (HR: 1.15, 95% CI: 0.84, 1.59) or low IgM (HR: 0.95, 95% CI: 0.73, 1.23) was not. Low immunoglobulin recovery in the first year was 2.5% (11), second year 8.2% (36), third year 10.1% (44) and fourth year 18.4% (80), and 60% (263) of acquired hypogammaglobulinaemia recovered over 4 years. CONCLUSION: The majority of acquired hypogammaglobulinaemia in adult patients with SLE is transient. Only low acquired IgA was associated with increased risk of infection among adult patients with SLE. Whether immunoglobulin replacement provides additional protective effect requires further investigation.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Almaghlouth I, Su J, Johnson SR, et al. Acquired low immunoglobulin levels and risk of clinically relevant infection in adult patients with systemic lupus erythematosus: a cohort study. Rheumatology (Oxford). 2021. PMID: 33006611. doi:10.1093/rheumatology/keaa641

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。